RankingsPricing
  1. JP-listed companies
  2. DAIKEN MEDICAL CO.,LTD
  3. Financials
  4. Capital expenditures

DAIKEN MEDICAL CO.,LTD【JP:7775】

Market cap
¥14.6B
P/E ratio
18.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-167+2.85%
Mar 31, 2024-162-18.21%
Mar 31, 2023-198-2.25%
Mar 31, 2022-203-34.27%
Mar 31, 2021-308+89.88%
Mar 31, 2020-162-18.30%
Mar 31, 2019-199-67.71%
Mar 31, 2018-615+3.29%
Mar 31, 2017-595-54.47%
Mar 31, 2016-1,308+294.19%
Mar 31, 2015-332

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)